SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6b0n'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LIN_A_TFPA155_1 (CALMODULIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 63 MET D 80 MET D 69 ALA D 78	None	1.25A	1linA-6b0nD: undetectable	1linA-6b0nD: 17.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	VAL D 111 ARG D 66 VAL D 18 PHE D 82	None	1.26A	1zzrA-6b0nD: undetectable 1zzrB-6b0nD: undetectable	1zzrA-6b0nD: 12.81 1zzrB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.27A	1zzuA-6b0nD: undetectable 1zzuB-6b0nD: undetectable	1zzuA-6b0nD: 12.81 1zzuB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BXE_B_1FLB2001_1 (SERUM ALBUMIN)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	5 / 12	LEU G 349 ILE G 272 PHE G 288 GLY G 451 LEU G 454	None	1.25A	2bxeB-6b0nG: undetectable	2bxeB-6b0nG: 9.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2J9C_A_ACTA1121_0 (HYPOTHETICAL NITROGEN REGULATORY PII-LIKE PROTEIN MJ0059)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 5	SER D 177 VAL D 169 SER D 179 VAL D 142	None	1.24A	2j9cA-6b0nD: undetectable 2j9cB-6b0nD: undetectable 2j9cC-6b0nD: undetectable	2j9cA-6b0nD: undetectable 2j9cB-6b0nD: undetectable 2j9cC-6b0nD: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NV4_A_ACTA148_0 (UPF0066 PROTEIN AF_0241)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	3 / 3	VAL G 506 GLU G 657 GLU G 654	None	0.80A	2nv4A-6b0nG: undetectable	2nv4A-6b0nG: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2RCT_A_RTLA140_0 (RETINOL-BINDING PROTEIN II, CELLULAR)	6b0n	PGV19 FAB HEAVY CHAIN PGV19 LIGHT CHAIN (Homo sapiens; Homo sapiens)	5 / 12	ILE E 48 TYR E 86 LEU E 47 GLN D 39 LEU D 45	None	1.39A	2rctA-6b0nE: undetectable	2rctA-6b0nE: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_E_SVRE510_2 (PHOSPHOLIPASE A2)	6b0n	PGV19 FAB HEAVY CHAIN PGV19 LIGHT CHAIN (Homo sapiens)	4 / 6	VAL E 39 GLN D 39 GLY E 100 LEU E 4	None	0.98A	3bjwE-6b0nE: undetectable	3bjwE-6b0nE: 18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BJW_F_SVRF509_3 (PHOSPHOLIPASE A2)	6b0n	PGV19 FAB HEAVY CHAIN PGV19 LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 39 GLN D 39 GLY E 100 LEU E 4	None	0.90A	3bjwF-6b0nE: undetectable	3bjwF-6b0nE: 18.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CFL_A_5CHA693_1 (LACTOTRANSFERRIN)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	4 / 4	THR G 37 VAL G 42 GLY G 531 THR G 529	None	1.04A	3cflA-6b0nG: undetectable	3cflA-6b0nG: 13.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.29A	3dqrA-6b0nD: undetectable 3dqrB-6b0nD: undetectable	3dqrA-6b0nD: 12.81 3dqrB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IB1_A_IMNA701_1 (LACTOTRANSFERRIN)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	4 / 4	PRO G 470 THR G 455 GLY G 459 THR G 461	None	1.08A	3ib1A-6b0nG: undetectable	3ib1A-6b0nG: 13.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.29A	3jx2A-6b0nD: undetectable 3jx2B-6b0nD: undetectable	3jx2A-6b0nD: 12.81 3jx2B-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.27A	3jx3A-6b0nD: undetectable 3jx3B-6b0nD: undetectable	3jx3A-6b0nD: 12.81 3jx3B-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX4_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 6	VAL D 111 ARG D 66 VAL D 18 PHE D 82	None	1.29A	3jx4A-6b0nD: undetectable 3jx4B-6b0nD: undetectable	3jx4A-6b0nD: 12.81 3jx4B-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.29A	3jx4A-6b0nD: undetectable 3jx4B-6b0nD: undetectable	3jx4A-6b0nD: 12.81 3jx4B-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.31A	3jx5A-6b0nD: undetectable 3jx5B-6b0nD: undetectable	3jx5A-6b0nD: 12.81 3jx5B-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.27A	3jx6A-6b0nD: undetectable 3jx6B-6b0nD: undetectable	3jx6A-6b0nD: 12.81 3jx6B-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NK7_A_SAMA770_0 (23S RRNA METHYLTRANSFERASE)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	5 / 12	ASN G 363 LEU G 452 GLY G 471 GLY G 472 ILE G 449	NAG G1363 (-2.5A) None None None None	1.04A	3nk7A-6b0nG: undetectable	3nk7A-6b0nG: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NK7_B_SAMB770_0 (23S RRNA METHYLTRANSFERASE)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	5 / 12	ASN G 363 LEU G 452 GLY G 471 GLY G 472 ILE G 449	NAG G1363 (-2.5A) None None None None	1.00A	3nk7B-6b0nG: undetectable	3nk7B-6b0nG: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.29A	3nlpA-6b0nD: undetectable 3nlpB-6b0nD: undetectable	3nlpA-6b0nD: 12.81 3nlpB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.26A	3nlqA-6b0nD: undetectable 3nlqB-6b0nD: undetectable	3nlqA-6b0nD: 12.81 3nlqB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	VAL D 111 ARG D 66 VAL D 18 PHE D 82	None	1.26A	3nlrA-6b0nD: undetectable 3nlrB-6b0nD: undetectable	3nlrA-6b0nD: 12.81 3nlrB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_E_W9TE506_1 (HEMOLYTIC LECTIN CEL-III)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	4 / 6	CYH G 604 THR G 605 CYH G 598 GLY G 597	None	1.14A	3w9tE-6b0nG: undetectable	3w9tE-6b0nG: 12.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZQT_A_30ZA1920_1 (ANDROGEN RECEPTOR)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	4 / 6	PRO G 43 GLY G 41 LEU G 544 ASN G 543	None	0.99A	3zqtA-6b0nG: undetectable	3zqtA-6b0nG: 13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AZV_A_SAMA1474_1 (WBDD)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	4 / 6	ARG G 151 ASP G 180 GLN G 422 GLU G 370	NAG G1133 ( 4.0A) None None None	0.96A	4azvA-6b0nG: undetectable	4azvA-6b0nG: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.26A	4cx3A-6b0nD: undetectable 4cx3B-6b0nD: undetectable	4cx3A-6b0nD: 12.81 4cx3B-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.25A	4cx4A-6b0nD: undetectable 4cx4B-6b0nD: undetectable	4cx4A-6b0nD: 12.81 4cx4B-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4D7B_A_TCWA1126_1 (TRANSTHYRETIN)	6b0n	PGV19 LIGHT CHAIN (Homo sapiens)	4 / 6	LEU E 132 ALA E 130 LEU E 178 THR E 181	None	1.12A	4d7bB-6b0nE: 3.3	4d7bB-6b0nE: 18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K39_A_SAMA504_0 (ANAEROBIC SULFATASE-MATURATING ENZYME)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	5 / 12	PHE G 391 ASN G 332 VAL G 292 ILE G 449 LEU G 452	None NAG G1331 ( 2.0A) None None None	1.26A	4k39A-6b0nG: undetectable	4k39A-6b0nG: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P66_A_MTXA201_1 (DIHYDROFOLATE REDUCTASE)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	5 / 11	ILE G 215 ALA G 55 LEU G 52 LEU G 483 ILE G 251	None	1.09A	4p66A-6b0nG: undetectable	4p66A-6b0nG: 17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PD9_A_ADNA501_1 (NUPC FAMILY PROTEIN)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	5 / 12	GLY G 312 VAL G 120 LEU G 122 SER G 306 ILE G 307	None	1.18A	4pd9A-6b0nG: undetectable	4pd9A-6b0nG: 14.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADD_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 6	VAL D 111 ARG D 66 VAL D 18 PHE D 82	None	1.28A	5addA-6b0nD: undetectable 5addB-6b0nD: undetectable	5addA-6b0nD: 12.81 5addB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADD_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.25A	5addA-6b0nD: undetectable 5addB-6b0nD: undetectable	5addA-6b0nD: 12.81 5addB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADE_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 6	VAL D 111 ARG D 66 VAL D 18 PHE D 82	None	1.30A	5adeA-6b0nD: undetectable 5adeB-6b0nD: undetectable	5adeA-6b0nD: 12.81 5adeB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADE_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.29A	5adeA-6b0nD: undetectable 5adeB-6b0nD: undetectable	5adeA-6b0nD: 12.81 5adeB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	VAL D 111 ARG D 66 VAL D 18 PHE D 82	None	1.29A	5g0pA-6b0nD: undetectable 5g0pB-6b0nD: undetectable	5g0pA-6b0nD: 12.81 5g0pB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6b0n	PGV19 FAB HEAVY CHAIN (Homo sapiens)	4 / 7	PHE D 82 VAL D 111 ARG D 66 VAL D 18	None	1.27A	5g0pA-6b0nD: undetectable 5g0pB-6b0nD: undetectable	5g0pA-6b0nD: 12.81 5g0pB-6b0nD: 12.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZJ_A_TEPA2401_1 (ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	4 / 8	LEU G 259 PHE G 391 LEU G 416 ILE G 414	None	0.90A	5mzjA-6b0nG: undetectable	5mzjA-6b0nG: 11.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O4Y_A_CCSA14_0 (PHE-MAA-ASN-PRO-HIS- LEU-SER-TRP-SER-TRP- 9KK-9KK-ARG-CCS-GLY- NH2)	6b0n	ENVELOPE GLYCOPROTEIN GP140 (Human immunodeficiency virus 1)	4 / 6	PHE G 468 LEU G 452 ARG G 469 GLY G 471	None	1.15A	5o4yA-6b0nG: undetectable	5o4yA-6b0nG: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1LIN_A_TFPA155_1","CALMODULIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  63;MET D  80;MET D  69;ALA D  78","None","1.25A","1linA-6b0nD:undetectable","1linA-6b0nD:17.57"],["1ZZR_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"VAL D 111;ARG D  66;VAL D  18;PHE D  82","None","1.26A","1zzrA-6b0nD:undetectable;1zzrB-6b0nD:undetectable","1zzrA-6b0nD:12.81;1zzrB-6b0nD:12.81"],["1ZZU_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.27A","1zzuA-6b0nD:undetectable;1zzuB-6b0nD:undetectable","1zzuA-6b0nD:12.81;1zzuB-6b0nD:12.81"],["2BXE_B_1FLB2001_1","SERUM ALBUMIN","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",5,"LEU G 349;ILE G 272;PHE G 288;GLY G 451;LEU G 454","None","1.25A","2bxeB-6b0nG:undetectable","2bxeB-6b0nG:9.21"],["2J9C_A_ACTA1121_0","HYPOTHETICAL NITROGEN REGULATORY PII-LIKE PROTEIN MJ0059","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"SER D 177;VAL D 169;SER D 179;VAL D 142","None","1.24A","2j9cA-6b0nD:undetectable;2j9cB-6b0nD:undetectable;2j9cC-6b0nD:undetectable","2j9cA-6b0nD:undetectable;2j9cB-6b0nD:undetectable;2j9cC-6b0nD:undetectable"],["2NV4_A_ACTA148_0","UPF0066 PROTEIN AF_0241","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",3,"VAL G 506;GLU G 657;GLU G 654","None","0.80A","2nv4A-6b0nG:undetectable","2nv4A-6b0nG:undetectable"],["2RCT_A_RTLA140_0","RETINOL-BINDING PROTEIN II, CELLULAR","6b0n","PGV19 FAB HEAVY CHAIN;PGV19 LIGHT CHAIN","Homo sapiens;Homo sapiens",5,"ILE E  48;TYR E  86;LEU E  47;GLN D  39;LEU D  45","None","1.39A","2rctA-6b0nE:undetectable","2rctA-6b0nE:undetectable"],["3BJW_E_SVRE510_2","PHOSPHOLIPASE A2","6b0n","PGV19 FAB HEAVY CHAIN;PGV19 LIGHT CHAIN","Homo sapiens",4,"VAL E  39;GLN D  39;GLY E 100;LEU E   4","None","0.98A","3bjwE-6b0nE:undetectable","3bjwE-6b0nE:18.49"],["3BJW_F_SVRF509_3","PHOSPHOLIPASE A2","6b0n","PGV19 FAB HEAVY CHAIN;PGV19 LIGHT CHAIN","Homo sapiens",4,"VAL E  39;GLN D  39;GLY E 100;LEU E   4","None","0.90A","3bjwF-6b0nE:undetectable","3bjwF-6b0nE:18.49"],["3CFL_A_5CHA693_1","LACTOTRANSFERRIN","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",4,"THR G  37;VAL G  42;GLY G 531;THR G 529","None","1.04A","3cflA-6b0nG:undetectable","3cflA-6b0nG:13.29"],["3DQR_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.29A","3dqrA-6b0nD:undetectable;3dqrB-6b0nD:undetectable","3dqrA-6b0nD:12.81;3dqrB-6b0nD:12.81"],["3IB1_A_IMNA701_1","LACTOTRANSFERRIN","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",4,"PRO G 470;THR G 455;GLY G 459;THR G 461","None","1.08A","3ib1A-6b0nG:undetectable","3ib1A-6b0nG:13.29"],["3JX2_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.29A","3jx2A-6b0nD:undetectable;3jx2B-6b0nD:undetectable","3jx2A-6b0nD:12.81;3jx2B-6b0nD:12.81"],["3JX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.27A","3jx3A-6b0nD:undetectable;3jx3B-6b0nD:undetectable","3jx3A-6b0nD:12.81;3jx3B-6b0nD:12.81"],["3JX4_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"VAL D 111;ARG D  66;VAL D  18;PHE D  82","None","1.29A","3jx4A-6b0nD:undetectable;3jx4B-6b0nD:undetectable","3jx4A-6b0nD:12.81;3jx4B-6b0nD:12.81"],["3JX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.29A","3jx4A-6b0nD:undetectable;3jx4B-6b0nD:undetectable","3jx4A-6b0nD:12.81;3jx4B-6b0nD:12.81"],["3JX5_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.31A","3jx5A-6b0nD:undetectable;3jx5B-6b0nD:undetectable","3jx5A-6b0nD:12.81;3jx5B-6b0nD:12.81"],["3JX6_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.27A","3jx6A-6b0nD:undetectable;3jx6B-6b0nD:undetectable","3jx6A-6b0nD:12.81;3jx6B-6b0nD:12.81"],["3NK7_A_SAMA770_0","23S RRNA METHYLTRANSFERASE","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",5,"ASN G 363;LEU G 452;GLY G 471;GLY G 472;ILE G 449","NAG G1363 (-2.5A);None;None;None;None","1.04A","3nk7A-6b0nG:undetectable","3nk7A-6b0nG:undetectable"],["3NK7_B_SAMB770_0","23S RRNA METHYLTRANSFERASE","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",5,"ASN G 363;LEU G 452;GLY G 471;GLY G 472;ILE G 449","NAG G1363 (-2.5A);None;None;None;None","1.00A","3nk7B-6b0nG:undetectable","3nk7B-6b0nG:undetectable"],["3NLP_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.29A","3nlpA-6b0nD:undetectable;3nlpB-6b0nD:undetectable","3nlpA-6b0nD:12.81;3nlpB-6b0nD:12.81"],["3NLQ_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.26A","3nlqA-6b0nD:undetectable;3nlqB-6b0nD:undetectable","3nlqA-6b0nD:12.81;3nlqB-6b0nD:12.81"],["3NLR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"VAL D 111;ARG D  66;VAL D  18;PHE D  82","None","1.26A","3nlrA-6b0nD:undetectable;3nlrB-6b0nD:undetectable","3nlrA-6b0nD:12.81;3nlrB-6b0nD:12.81"],["3W9T_E_W9TE506_1","HEMOLYTIC LECTIN CEL-III","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",4,"CYH G 604;THR G 605;CYH G 598;GLY G 597","None","1.14A","3w9tE-6b0nG:undetectable","3w9tE-6b0nG:12.28"],["3ZQT_A_30ZA1920_1","ANDROGEN RECEPTOR","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",4,"PRO G  43;GLY G  41;LEU G 544;ASN G 543","None","0.99A","3zqtA-6b0nG:undetectable","3zqtA-6b0nG:13.50"],["4AZV_A_SAMA1474_1","WBDD","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",4,"ARG G 151;ASP G 180;GLN G 422;GLU G 370","NAG G1133 ( 4.0A);None;None;None","0.96A","4azvA-6b0nG:undetectable","4azvA-6b0nG:undetectable"],["4CX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.26A","4cx3A-6b0nD:undetectable;4cx3B-6b0nD:undetectable","4cx3A-6b0nD:12.81;4cx3B-6b0nD:12.81"],["4CX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.25A","4cx4A-6b0nD:undetectable;4cx4B-6b0nD:undetectable","4cx4A-6b0nD:12.81;4cx4B-6b0nD:12.81"],["4D7B_A_TCWA1126_1","TRANSTHYRETIN;TRANSTHYRETIN","6b0n","PGV19 LIGHT CHAIN","Homo sapiens",4,"LEU E 132;ALA E 130;LEU E 178;THR E 181","None","1.12A","4d7bB-6b0nE:3.3","4d7bB-6b0nE:18.97"],["4K39_A_SAMA504_0","ANAEROBIC SULFATASE-MATURATING ENZYME","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",5,"PHE G 391;ASN G 332;VAL G 292;ILE G 449;LEU G 452","None;NAG G1331 ( 2.0A);None;None;None","1.26A","4k39A-6b0nG:undetectable","4k39A-6b0nG:undetectable"],["4P66_A_MTXA201_1","DIHYDROFOLATE REDUCTASE","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",5,"ILE G 215;ALA G  55;LEU G  52;LEU G 483;ILE G 251","None","1.09A","4p66A-6b0nG:undetectable","4p66A-6b0nG:17.76"],["4PD9_A_ADNA501_1","NUPC FAMILY PROTEIN","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",5,"GLY G 312;VAL G 120;LEU G 122;SER G 306;ILE G 307","None","1.18A","4pd9A-6b0nG:undetectable","4pd9A-6b0nG:14.03"],["5ADD_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"VAL D 111;ARG D  66;VAL D  18;PHE D  82","None","1.28A","5addA-6b0nD:undetectable;5addB-6b0nD:undetectable","5addA-6b0nD:12.81;5addB-6b0nD:12.81"],["5ADD_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.25A","5addA-6b0nD:undetectable;5addB-6b0nD:undetectable","5addA-6b0nD:12.81;5addB-6b0nD:12.81"],["5ADE_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"VAL D 111;ARG D  66;VAL D  18;PHE D  82","None","1.30A","5adeA-6b0nD:undetectable;5adeB-6b0nD:undetectable","5adeA-6b0nD:12.81;5adeB-6b0nD:12.81"],["5ADE_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.29A","5adeA-6b0nD:undetectable;5adeB-6b0nD:undetectable","5adeA-6b0nD:12.81;5adeB-6b0nD:12.81"],["5G0P_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"VAL D 111;ARG D  66;VAL D  18;PHE D  82","None","1.29A","5g0pA-6b0nD:undetectable;5g0pB-6b0nD:undetectable","5g0pA-6b0nD:12.81;5g0pB-6b0nD:12.81"],["5G0P_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6b0n","PGV19 FAB HEAVY CHAIN","Homo sapiens",4,"PHE D  82;VAL D 111;ARG D  66;VAL D  18","None","1.27A","5g0pA-6b0nD:undetectable;5g0pB-6b0nD:undetectable","5g0pA-6b0nD:12.81;5g0pB-6b0nD:12.81"],["5MZJ_A_TEPA2401_1","ADENOSINE RECEPTOR A2A,SOLUBLE CYTOCHROME B562,ADENOSINE RECEPTOR A2A","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",4,"LEU G 259;PHE G 391;LEU G 416;ILE G 414","None","0.90A","5mzjA-6b0nG:undetectable","5mzjA-6b0nG:11.44"],["5O4Y_A_CCSA14_0","PHE-MAA-ASN-PRO-HIS-LEU-SER-TRP-SER-TRP-9KK-9KK-ARG-CCS-GLY-NH2","6b0n","ENVELOPE GLYCOPROTEIN GP140","Human immunodeficiency virus 1",4,"PHE G 468;LEU G 452;ARG G 469;GLY G 471","None","1.15A","5o4yA-6b0nG:undetectable","5o4yA-6b0nG:undetectable"]]